Literature DB >> 7732013

A simple p53 functional assay for screening cell lines, blood, and tumors.

J M Flaman1, T Frebourg, V Moreau, F Charbonnier, C Martin, P Chappuis, A P Sappino, I M Limacher, L Bron, J Benhattar.   

Abstract

Mutations in the p53 gene are implicated in the pathogenesis of half of all human tumors. We have developed a simple functional assay for p53 mutation in which human p53 expressed in Saccharomyces cerevisiae activates transcription of the ADE2 gene. Consequently, yeast colonies containing wild-type p53 are white and colonies containing mutant p53 are red. Since this assay tests the critical biological function of p53, it can distinguish inactivating mutations from functionally silent mutations. By combining this approach with gap repair techniques in which unpurified p53 reverse transcription-PCR products are cloned by homologous recombination in vivo it is possible to screen large numbers of samples and multiple clones per sample for biologically important mutations. This means that mutations can be detected in tumor specimens contaminated with large amounts of normal tissue. In addition, the assay detects temperature-sensitive mutants, which give pink colonies. We show here that this form of p53 functional assay can be used rapidly to detect germline mutations in blood samples, somatic mutations in tumors, and mutations in cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732013      PMCID: PMC42082          DOI: 10.1073/pnas.92.9.3963

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity.

Authors:  A Skerra
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

2.  Mammalian p53 can function as a transcription factor in yeast.

Authors:  E Schärer; R Iggo
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 3.  The rapid detection of unknown mutations in nucleic acids.

Authors:  M Grompe
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

4.  Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.

Authors:  J Toguchida; T Yamaguchi; S H Dayton; R L Beauchamp; G E Herrera; K Ishizaki; T Yamamuro; P A Meyers; J B Little; M S Sasaki
Journal:  N Engl J Med       Date:  1992-05-14       Impact factor: 91.245

5.  Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.

Authors:  Y Sameshima; Y Tsunematsu; S Watanabe; T Tsukamoto; K Kawa-ha; Y Hirata; H Mizoguchi; T Sugimura; M Terada; J Yokota
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

6.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

7.  Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Y A Tong; K Devadas; Z Q Zou; V W Sykes; Y Chen; W A Blattner; K Pirollo; E H Chang
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

8.  A functional screen for germ line p53 mutations based on transcriptional activation.

Authors:  T Frebourg; N Barbier; J Kassel; Y S Ng; P Romero; S H Friend
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

9.  A yeast expression system for human galactose-1-phosphate uridylyltransferase.

Authors:  J L Fridovich-Keil; S Jinks-Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  112 in total

1.  Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay.

Authors:  G K Kovvali; B Mehta; C B Epstein; S G Lutzker
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Authors:  M Partridge
Journal:  Ann R Coll Surg Engl       Date:  1999-01       Impact factor: 1.891

3.  Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.

Authors:  Isabelle Soubeyran; Isabelle Mahouche; Aude Grigoletto; Thierry Leste-Lasserre; Guillaume Drutel; Christophe Rey; Stephane Pedeboscq; France Blanchard; Veronique Brouste; Jean-Christophe Sabourin; Yves Bécouarn; Josy Reiffers; François Ichas; Francesca De Giorgi
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast.

Authors:  Jana Smardová; Sárka Pavlová; Hana Koukalová
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

5.  Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Authors:  Michael A Resnick; Alberto Inga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

6.  Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.

Authors:  V Abkevich; A Zharkikh; A M Deffenbaugh; D Frank; Y Chen; D Shattuck; M H Skolnick; A Gutin; S V Tavtigian
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 7.  TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.

Authors:  Ashkan Shahbandi; Hoang D Nguyen; James G Jackson
Journal:  Trends Cancer       Date:  2020-02-05

8.  p53: a molecular marker for the detection of cancer.

Authors:  Mark T Boyd; Nikolina Vlatkovic
Journal:  Expert Opin Med Diagn       Date:  2008-09

9.  The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.

Authors:  Dirk O Bauerschlag; Christian Schem; Marion T Weigel; Constantin Von Kaisenberg; Alexander Strauss; Thomas Bauknecht; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

10.  High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Authors:  Jana Smardova; Kvetoslava Liskova; Barbora Ravcukova; Lenka Kubiczkova; Sabina Sevcikova; Jaroslav Michalek; Miluse Svitakova; Vaclav Vybihal; Leos Kren; Jan Smarda
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.